Home>>Signaling Pathways>> GPCR/G protein>> Glucocorticoid Receptor>>Clobetasol propionate

Clobetasol propionate (Synonyms: CCl-4725, CGP 9555, Clobetasol 17-Propionate)

Catalog No.GC11976

Glucocorticoid receptor agonist

Products are for research use only. Not for human use. We do not sell to patients.

Clobetasol propionate Chemical Structure

Cas No.: 25122-46-7

Size Price Stock Qty
10mM (in 1mL DMSO)
$36.00
In stock
50mg
$49.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Clobetasol propionate is a anti-inflammatory corticosteroid used to treat various skin disorders.Target: Glucocorticoid ReceptorClobetasol propionate is a corticosteroid of the glucocorticoid class used to treat various skin disorders including eczema and psoriasis. It is also highly effective for contact dermatitis caused by exposure to poison ivy/oak. Clobetasol belongs to US Class I (Europe: class IV) of the corticosteroids, making it one of the most potent available. It comes in shampoo, mousse, ointment and emollient cream presentations. It has very high potency and typically should not be used with occlusive dressings, or for extended continuous use (beyond two weeks). It is also used to treat several auto-immune diseases including alopecia areata, vitiligo and lichen planus (auto immune skin nodules). From Wikipedia.

References:
[1]. http://en.wikipedia.org/wiki/Clobetasol_propionate

Reviews

Review for Clobetasol propionate

Average Rating: 5 ★★★★★ (Based on Reviews and 7 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Clobetasol propionate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.